✦ LIBER ✦

Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft

✍ Scribed by Rhona Stein; Susan Chen; Sara Haim; David M. Goldenberg

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 129 KB
Volume: 80
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2636::aid-cncr39>3.0.co;2-b

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND. The purpose of this investigation was to compare the therapeutic

Rhona Stein, Ph

📜 SIMILAR VOLUMES

Use of an yttrium 90 labeled antibody fo

Use of an yttrium 90 labeled antibody for the treatment of human colon cancer xenografts in nude mice

✍ Craig S. Heacock; Ann M. Blake; Christopher J. D'Aleo; Vernon L. Alvarez 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 60 KB

Combined 90Yttrium-DOTA-labeled PAM4 ant

Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft

✍ David V. Gold; David E. Modrak; Keith Schutsky; Thomas M. Cardillo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 132 KB

## Abstract We have examined the application of ^90^Y‐DOTA‐cPAM4, anti‐MUC1 IgG, in combination with the front‐line drug gemcitabine as a potential therapeutic for pancreatic cancer. Athymic nude mice bearing CaPan1 human pancreatic cancer xenografts were administered 2 mg of gemcitabine on days 0,